Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03780816 · ClinicalTrials.gov registry record
Variation in Cancer Centers' End-of-Life Quality
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 473
- Enrollment target
NCT03780816 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 473 participants.
The verdict
NCT03780816 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 473 participants
- Enrollment target
Study Summary
This is a qualitative study of local organizational and provider practice norms, and how these norms influence patient and family expectations and provider decision-making heuristics for minority patients with advanced cancer at major US cancer centers. Outpatient visits with oncologists will be observed and documented via hand-written field notes. Semi-structured interviews with selected participating clinicians, patients, caregivers, and other informants will follow the initial observation.
Interventions
- OTHER Observation of provider-patient interactions and interviews
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 473 participants |
| Start Date | 2019-07-05 |
| Est. Completion | 2021-07-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03780816
The ClinicalTrials.gov registry entry for NCT03780816 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 473 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observation of provider-patient interactions and interviews is the first listed.
NCT03780816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03780816 about?
NCT03780816 is a clinical study titled "Variation in Cancer Centers' End-of-Life Quality". This is a qualitative study of local organizational and provider practice norms, and how these norms influence patient and family expectations and provider decision-making heuristics for minority patients with advanced cancer at major US cancer centers. Outpatient visits with oncologists will be obs...
What is the current status of trial NCT03780816?
This trial is currently completed. The enrollment target is 473 participants. The study started on 2019-07-05. Estimated completion is 2021-07-15.
What interventions are being tested in trial NCT03780816?
The interventions under investigation include: Observation of provider-patient interactions and interviews (OTHER).
Who is sponsoring clinical trial NCT03780816?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.